Keywords: mylan, generic, prilosec, does, infringe, az, patent

Mylan's generic Prilosec does not infringe on AZ patent

Article | 16 June 2008

Print This

US generics giant Mylan's release of a generic version of the Anglo-Swedish major drug firm AstraZeneca's branded proton pump inhibitor ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in